SCHEMBL9380810

SCHEMBL9380810

Cc1ccc(/C=C/c2ccc([N+](=O)[O-])cc2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.54
▸ RAB9A P51151 4/20 0.54
▸ MAPT P10636 4/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ HTT P42858 1/20 0.54
▸ ACHE P22303 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ PTGS2 P35354 6/20 0.51
▸ NFE2L2 Q16236 1/20 0.51
▸ MAOA P21397 1/20 0.51
▸ MAOB P27338 1/20 0.51
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ HPGD P15428 1/20 0.50
▸ APP P05067 1/20 0.50
▸ FBP1 P09467 1/20 0.49
▸ PTGS1 P23219 2/20 0.48
▸ CYP19A1 P11511 2/20 0.47
▸ PIM1 P11309 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9380814 1.00 NPC1 (0.54) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL5514260 0.83 ACHE (0.75) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL17589690 0.83 ACHE (0.75) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL2681912 0.83 ACHE (0.75) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL14129680 0.81 KDM4E (0.53) NPC1RAB9AMAPTSMN1; SMN2HTT
SCHEMBL10388270 0.80 RAB9A (0.65) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL10388268 0.80 RAB9A (0.65) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL9382222 0.79 MAPT (0.55) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL9382219 0.79 MAPT (0.55) NPC1RAB9AMAPTSMN1; SMN2MAPK1
SCHEMBL20464764 0.78 SLC2A1 (0.56) NPC1RAB9AMAPTSMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0356234-B1 New Benzazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-05-11 — — EP disclosed
US-5047411-A Antiulcer Agents, H2-Receptor Antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-09-10 — — US disclosed
EP-0356234-A2 New Benzazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-02-28 — — EP disclosed
Send feedback